Federal Reserve Governor Randal Quarles said he will resign at the end of the December, leaving another vacant spot for the White House to fill and giving President Biden a chance to reshape the U.S. central bank. Quarles recently finished out his term as the Fed’s first-ever vice chairman of supervision of U.S. banks, a
Month: November 2021
What Is a Blockchain ETF? Blockchain exchange traded funds (ETF) are ETFs that hold stocks of companies that profit from blockchain technology or have business operations tied to blockchain technology. While regulators have rejected numerous bitcoin ETFs, they have approved a few blockchain-based ETFs. Note that in October 2021 the first cryptocurrency ETF started trading—the
In this article QCOM QRVO Medical syringe is seen with Moderna company logo displayed on a screen in the background in this illustration photo taken in Poland. Jakub Porzycki | NurPhoto | Getty Images Check out the companies making headlines in midday trading. Moderna — Moderna shares tumbled 19% after a weaker-than-expected quarterly report. The drug
QuantumScape (NYSE:QS) stock may very well start soaring on the development of solid-state batteries and the company’s underlying innovation. Source: Michael Vi / Shutterstock.com Electric vehicles are the future. A commonly repeated mantra, it’s become such a meme that expressing a contrarian argument is sure to generate heat. However, some components of EVs are challenging,
With its massive price decline so far this year, is now the time to follow the crowd’s changing diagnosis on Teladoc (NYSE:TDOC)? Not so fast. TDOC stock may be down more than 25% year-to-date, and down about 50% from its all-time high of $308 per share. But despite this drop, and the fact it’s been trending
The buy now, pay later (BNPL) market is red-hot, and related stocks are reaping the benefits or doubling down. Affirm Holdings (NASDAQ:AFRM) exploded from $50 to over $160 since May. Paidy was just acquired by PayPal (NASDAQ:PYPL) for $2.7 billion. Afterpay was acquired by Square (NYSE:SQ) in a $29 billion deal. Even Amazon (NASDAQ:AMZN), Target (NYSE:TGT)
Blackstone Inc. is investing as much as $250 million in U.K. biotechnology company Autolus Therapeutics PLC to fund the final stages of development of a new therapy to treat a serious form of leukemia, the companies said. Of the total investment, as much as $150 million will support the development and commercialization of obecabtagene autoleucel, a cell therapy that
Jeff Bezos, left, and Elon Musk Getty Images; Reuters The U.S. Federal Court of Claims ruled against Jeff Bezos’ Blue Origin in the company’s lawsuit versus NASA over a lucrative astronaut lunar lander contract awarded to Elon Musk’s SpaceX earlier this year. Federal judge Richard Hertling sided with the defense in his ruling, completing a
You know a health savings account (HSA) helps pay for out-of-pocket medical costs, but it may surprise you to learn that this tax-advantaged account could be a superior retirement savings vehicle, too. It has become ingrained in us that we should max out our 401(k) or other workplace-defined contribution plan as the best way to
A worker wields hinges to the company’s largest commercial asphalt paver at the Calder Brothers’ facility in Taylors, South Carolina, U.S., July 19, 2021. Brandon Granger | Calder Brothers Corporation | Reuters Hiring is expected to have picked up at a solid pace and wages likely continued to climb in October, as Covid receded and
After an incredible run-up in the days after its initial public offering, volatility in Robinhood (NASDAQ:HOOD) is mostly absent. That did not stop the bearish selling on HOOD stock from accelerating after the company posted quarterly results on Oct. 26. Source: OpturaDesign / Shutterstock.com Robinhood fell after posting third-quarter results. What did investors not like?
Virgin Galactic (NYSE:SPCE) has been on a bad downward spiral. From a recent peak of $55.91 on June 25, SPCE stock is now near a low point of $19.55. However, despite this, don’t act on the urge just yet to bargain hunt in this stock. Source: rafapress / Shutterstock.com I forewarned investors that this could
Although all eyes have been on the searing path that benchmark equity indices have blazed in 2021, initial public offerings (IPOs) have had their own impressive bull market. In fact, Reuters reported in mid-June that U.S. IPOs hit an annual record in less than six months. So if 2020 was the year of the novel
After Zillow Z, -2.12% ZG, -3.43% shocked investors by announcing that it would leave the business of buying and selling homes altogether — just weeks after the company initially indicated it was simply pausing its home-flipping efforts — myriad questions emerged. A central one has been whether the problems Zillow encountered were unique to its
In this article F CZR SHOO Ford CEO Jim Farley poses with the Ford F-150 Lightning pickup truck in Dearborn, Michigan, May 19, 2021. Rebecca Cook | Reuters It seems each passing trading session brings a torrent of quarterly earnings and sharp swings for the stocks of the companies reporting results. Positive prints can have
The auto company that some Americans may still refer to as Chrysler is now part of a conglomerate called Stellantis NV (STLA) based in Amsterdam. Fiat Chrysler Automobiles officially merged with PSA Group, owner of the Peugeot automobile brand, in early 2021. The combination makes Stellantis the world’s fourth-largest automobile maker, with 14 vehicle brands
In this article GOOS-CA DKNG PFE LYV WEED-CA PTON Check out the companies making headlines before the bell: Pfizer (PFE) – The drug maker’s shares surged 9.4% in premarket trading after a study showed that its experimental Covid-19 antiviral pill reduced the risk of hospitalization and death by nearly 90%. Pfizer said it will ask
It has been an excellent third-quarter earnings season so far. Of the S&P 500 stocks that have reported earnings, a majority have beaten analyst estimates. According to Factset Insight, 56% of the index companies have reported earnings so far in Q3 2021. Of those, 82% beat the consensus earnings per share (EPS). That’s higher than
Ocugen (NASDAQ:OCGN) is a stock that I continue to be wrong about. Over the past month, OCGN stock has gained more than 80%, greatly testing my patience. The stock has fallen from the $17 mark it reached this morning, but is still higher than I expected last month. Source: shutterstock.com/PhotobyTawat In my last article about
I first came in contact with Palantir (NYSE:PLTR) stock earlier this year and immediately knew it was something special. The underlying bullish thesis was clear, so I traded it successfully in the past few months. The easiest opportunities came when it fell in sympathy to other small-cap stocks. Source: Ascannio / Shutterstock.com The problem with
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 22
- Next Page »